https://www.selleckchem.com/pr....oducts/acss2-inhibit
Combining prevalence and per-person excess expenditures, the three costliest complications were nephropathy, heart failure, and ischemic heart disease (IHD) for DBEs, compared to neuropathy, nephropathy, and IHD for NDBEs. Our study provides data that can be used for assessing the health care resources needed for managing DRCs and evaluating cost-effectiveness of interventions to prevent and management DRCs. Our study provides data that can be used for assessing the health care resources needed for managing DRCs and evaluating c
Like
Comment
Share
